Saskia Middeldorp - Biography#

Saskia Middeldorp is Professor of Medicine and Head of the Department of Internal Medicine of the Radboud University Medical Center in Nijmegen, The Netherlands. Prior to her transfer to Nijmegen in January 2021, she has been a professor of Medicine at Amsterdam University Medical Centers for over 10 years, leading the clinical thrombosis and haemostasis research lines of the Department of Vascular Medicine. Since January 2023, Saskia Middeldorp has been elected to be one of the 4 Research Domain Leaders in the Radboudumc Research Institution for Medical Innovation.

Her present research focuses on several aspects of hereditary and acquired thrombophilia, women’s issues in thrombosis and haemostasis, and the clinical evaluation of new anticoagulants and antidotes. She is principal investigator of practice-changing trials such as the investigator-initiated ALIFE, ALIFE2 and Highlow randomized controlled trials.

Saskia Middeldorp is elected council member of the International Society of Thrombosis and Haemostasis (www.isth.org) immediate past chair of the INVENT-VTE network (www.invent-vte.org), and past president of the Netherlands Society of Thrombosis and Haemostasis.

She is Associate Editor of the Journal of Thrombosis and Haemostasis (2021 impact factor 16.036) and Editorial Board Member of Blood (2021 impact factor 25.669).

In December 2016, she gave the prestigious Ham-Wasserman Lecture and received the accompanying award in recognition of pioneering work in inherited thrombophilia at the annual American Society of Hematology (ASH) meeting in San Diego.

In October 2021, she received the Heijmans van den Bergh penning, a once-per-five year honorary distinction of the Netherlands Internal Medicine Society for her achievements in terms of science, education, governance and being a role model for young internists. (For more details see 1.14)

She is chair of the Thrombophilia Chapter of ASH VTE Guidelines (expected 2023). Saskia Middeldorp has co-authored the Pregnancy chapter of the ASH pregnancy guideline in 2018, as well as the 9th Edition Antithrombotic Guidelines of the American College of Chest Physicians (ACCP) in 2012.

Saskia Middeldorp has been supervisor ((co)promotor) of 28 PhD students and currently supervises 7 PhD students. She has co-authored over 400 peer-reviewed papers and several book chapters, and reviews manuscripts for international scientific journals.